Electronic Skin Patch SkinWear: Wearables That Disappear Into Your Skin
SkinWear, the electronic skin patch developed jointly by the University of Tokyo and JDI, is just 0.04 millimeters thick and can be applied to the skin to monitor heart rate, body temperature, blood oxygen, and other vital signs. After completing its monitoring task, the patch is naturally metabolized and absorbed by the skin within 14 days.
SkinWear, the electronic skin patch developed jointly by the University of Tokyo and JDI (Japan Display Inc.), is a new product form for consumer electronics. The ultra-thin patch is just 0.04 millimeters thick and can be applied to the skin to monitor heart rate, body temperature, blood oxygen, and blood glucose. After completing its monitoring task, the patch is naturally metabolized and absorbed by the skin within 14 days.
At the core of SkinWear is an organic electronic circuit built on biodegradable materials. The base material is polylactic acid, or PLA, a biocompatible polymer already widely used in medical sutures. Silicon-based transistors are replaced with organic semiconductors, and the conductive traces use a hybrid ink of graphene and silver nanowires.
On the sensor side, SkinWear integrates five different microsensors. The heart rate sensor picks up electrical potential changes at the skin surface, the body temperature sensor uses a tiny thermistor, the blood oxygen sensor relies on differences in the reflectance of red and infrared light, and the blood glucose sensor uses subcutaneous microneedles to extract tiny amounts of interstitial fluid. The entire sensor array weighs less than 0.5 grams.
Battery life is a key engineering challenge for SkinWear. Organic circuits operate at lower voltage and consume less energy, but the 0.04-millimeter thickness severely caps battery capacity. JDI's solution is a dual energy harvesting system based on the body's thermoelectric and triboelectric effects. The patch can continuously harvest small amounts of energy from skin temperature gradients and friction.
Measured data show SkinWear can run continuously for 14 days, with monitoring data streamed in real time over low-power Bluetooth to a paired smartphone. Professor Takao Someya of the University of Tokyo Graduate School of Engineering said this is the next form of wearable: devices that integrate into the body rather than being worn on it.
On applications, SkinWear's first market is chronic disease management. Japan's Ministry of Health, Labour and Welfare has approved SkinWear for continuous blood glucose monitoring in diabetics, replacing the traditional finger-prick method. Each SkinWear patch is priced at 780 yen, about 5.3 dollars, and is simply discarded after use.
SkinWear's safety and environmental profile have been validated. Animal experiments at the University of Tokyo showed that the patch's degradation products are mainly water and carbon dioxide, with no negative environmental impact. Japan's National Institute for Environmental Studies confirmed that SkinWear's degradation does not release harmful substances into the environment.
SkinWear still has some experience-related limits. The patch tends to come off when sweating or showering, and Professor Someya said the team is developing a more water-resistant next-generation product expected in the second half of 2026. The patches also cannot be reused, which differs from the reuse habits of conventional wearables.
On the business model, SkinWear is sold by subscription, with a fresh batch of patches shipped each month. JDI has partnered with Japan's largest pharmacy chain Welcia, and the subscription can be set up at any of Welcia's 120,000 stores. This channel footprint will accelerate SkinWear's penetration in the Japanese market.
Professor Someya disclosed that the team's next step is exploring the use of SkinWear for drug delivery. The patch would not only monitor vital signs but also automatically release insulin when blood glucose is abnormal. If that sense-and-respond loop is realized, it would reshape the paradigm for chronic disease management.
Disclaimer
Content is AI-generated. Do not use it as a basis for real decisions. Do not cite it as factual reporting.